SEC Form 4 · accession 0001493152-15-003743
Targeted Medical Pharma, Inc. · TRGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Richard Wenkart
Director · 10% Owner
Period of report
Jun 30, 2015
Accepted (ET)
Aug 14, 2015 · 4:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420030
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 30, 2015 | A | 40,183 | $0.30 | A | 2,063,606 | I | By DERMA MEDICAL SYSTEM INC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person is the owner and President of Derma Medical Systems Inc.